5 Takeaways From FDA's Off-Label Promo Forum
The U.S. Food and Drug Administration on Wednesday heard sharply divergent views about off-label promotion of drugs and medical devices, with manufacturers and BigLaw attorneys urging more leeway while consumer advocates...To view the full article, register now.
Already a subscriber? Click here to view full article